Frontiers in nutrigenomics, proteomics, metabolomics and cancer prevention

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 551, Issue 1-2, 2004, Pages 51-64

  Davis, Cindy D ^a   Milner, John ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

1,25 D3; 25 dihydroxyvitamin D3; 2D PAGE; DADS; dialllyl disulfide; ERK; extracellular signal regulated kinase; glutathione S transferase; GST; manganese dependent superoxide dismutase; MnSOD; MS; two dimensional polyacrylamide gel electrophoresis

Indexed keywords

BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE PHOSPHATASE; SELENIUM;

ANGIOGENESIS; APOPTOSIS; BEHAVIOR; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CELL CYCLE; DIET; DNA METHYLATION; DNA REPAIR; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOMICS; HUMAN; INFORMATION; MEDICAL LITERATURE; MOLECULAR GENETICS; MOLECULAR WEIGHT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUTRITION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; SURFACE PROPERTY;

ANTICARCINOGENIC AGENTS; DIET; HUMANS; NEOPLASMS; NUTRITION PHYSIOLOGY; PROTEOME;

EID: 3042628056     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2004.01.012     Document Type: Review

References (105)

1. The Surgeon General's Report on Nutrition and Health: Department of Health and Human Services, Public Health Service, 1988, Washington, DC, US.
2. World Cancer Research Fund, American Institute for Cancer Research, Food, Nutrition and the Prevention of Cancer: A Global Perspective, American Institute for Cancer Research, Washington, DC, 1997.
3. Surh Y.-J. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer. 3:2003;768-780
4. Ross S.A., Poirier L. in: Proceedings of the Trans-HHS Workshop: Diet, DNA Methylation Processes and Health. J. Nutr. 132:2002;2329s-2484s
5. Davis C.D. Use of exfoliated cells from target tissues to predict responses to bioactive food components. J. Nutr. 133:2003;1769-1772
6. Yan H., Zhou W. Allelic variations in gene expression. Curr. Opin Oncol. 16:2004;39-43
7. Jhanwar-Uniyal M. BRCA1 in cancer, cell cycle and genomic stability. Front. Biosci. 8:2003;S1107-S1117
8. Potter J.D. Colorectal cancer: molecules and populations. J. Natl. Cancer Inst. 91:1999;916-932
9. Ambrosone C.B., Freudenheim J.L., Thompson P.A., Bowman E., Vena J.E., Marshall J.R., Graham S., Laughlin R., Nemoto T., Shields P. Manganese superoxide dismutase (MnSOD) genetic polymorphisms. Cancer Res. 59:1999;602-606
10. Dietz A.C., Zheng W., Leff M.A., Gross M., Wen W.Q., Doll M.A., Xiao G.H., Folsom A.R., Hein D.W. N-acetyltransferase-2 genetic polymorphism, well-done meat intake and breast cancer risk among postmenopausal women. Cancer Epidemiol. Biomarkers Prev. 9:2000;905-910
11. Vineis P., McMichael A. Interplay between heterocyclic amines in cooked meat and metabolic phenotype in the etiology of colon cancer. Cancer Causes Control. 7:1996;479-486
12. Seow A., Yuan J.M., Sun C.L., Van Den Berg D., Lee H.P., Yu M.C. Dietary isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the Singapore Chinese Health Study. Carcinogenesis. 23:2002;2055-2061
13. Bailey L.B., Gregory J.F. Polymorphism of metheletetrahydrofolate reductase and other enzymes: metabolic significance. J. Nutr. 129:1999;919-922
14. Chen J., Giovannucci E.L., Hunter D.J. MTHFR polymorphism, methyl-replete diets and the risk of colorectal carcinoma and adenoma among US men and women: an example of gene-environment interactions in colorectal tumorigenesis. J. Nutr. Suppl. 129:1999;560s-564s
15. Frost P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J., den Heijer M., Kluijtmans L.A., van den Heuvel L.P. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10:1995;111-113
16. Margate T., Tsuji E., Kiyohara C., Eguchi H., Oda T., Shinchi K., Kono S. Relation of plasma folate and methyltetrahydrofolate reductase C677T polymorphism to colorectal adenomas. Int. J. Epidemiol. 32:2003;64-66
17. Suh J.R., Hervig A.K., Stover P.J. New perspectives on folate catabolism. Annu. Rev. Nutr. 21:2001;255-282
18. Esteller M., Garcia A., Martinez-Palones J.M., Xercavins J., Reventos J. Germ line polymorphisms in cytochrome-P4501A1 (C4887CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis. 12:1997;2307-2311
19. Gershoni-Baruch R., Dagan E., Israeli D., Kasinetz L., Kadouri E., Friedman E. Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women. Eur. J. Cancer. 18:2000;2313-2316
20. Campbell I.G., Baxter S.W., Eccles D.M., Choong D.Y.H. Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer. Breast Cancer Res. R14:2002;1-4
21. Choi S.W., Mason J.B. Folate status: effects on pathways of colorectal carcinogenesis. J. Nutr. 132:2002;2413S-2418S
22. Mason J.B. Biomarkers of nutrient exposure and status in one-carbon (methyl)metabolism. J. Nutr. 133:2003;941S-947S
23. Banerjee P., Chatterjee M. Antiproliferative role of Vitamin D and its analogs-a brief overview. Mol. Cell. Biochem. 253:2003;247-254
24. Osborne J.E., Hutchinson P.E. Vitamin D and systemic cancer: is this relevant to malignant melanoma? Br. J. Dermatol. 147:2002;197-213
25. Arai H., Miyamoto K., Taketani Y., Yamamoto H., Iemori Y., Morita K., Tokai T., Nishinsho T., Mori S., Takeda E. A Vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J. Bone Miner. Res. 12:1997;915-921
26. Whitfield G.K., Remus L.S., Jurutka P.W., Zitzer H., Oza A.K., Dang H.T., Haussler C.A., Galligan M.A., Thatcher M.L., Encinas Dominguez C., Haussler M.R. Functionally relevant polymorphisms in the human nuclear Vitamin D receptor gene. Mol. Cell Endocrinol. 177:2001;145-159
27. Wong H.L., Seow A., Arakawa K., Lee H.P., Yu M.C., Ingles S.A. Vitamin D receptor start codon polymorphism and colorectal cancer risk: effect modification by dietary calcium and fat in Singapore Chinese. Carcinogenesis. 24:2003;1091-1095
28. Slattery M.L., Yakumo K., Hoffman M., Neuhausen S. Variants of the VDR gene and risk of colon cancer (United States). Cancer Causes Control. 12:2001;359-364
29. Peters U., McGlynn K.A., Chatterjee N., Gunter E., Garcias-Closas M., Rothman N., Sinha R. Vitamin D, calcium and Vitamin D receptor polymorphism in colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 10:2001;1267-1274
30. Kim H., Newcomb P.A., Ulrich C.M., Potter J.D. Vitamin D receptor polymorphisms and the risk of colorectal adenomas. Am. J. Epidemiol. S151:2000;S49
31. Slattery M.L., Yakumo K., Hoffman M., Neuhausen S. Variants of the VDR gene and the risk of colon cancer (United States). Cancer Causes Control. 12:2001;359-364
32. Uitterlinden A.G., Fang Y., Arjan A.P., Bergink P., van Meurs J.B.J., van Leeuwen H.P.T.M., Pols H.A.P. The role of Vitamin D receptor gene polymorphisms in bone biology. Mol. Cell. Endocrinol. 197:2002;15-21
33. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer E., Kinzler K.W., Vogelstein B. WAF1, a potential mediation of p53 tumor suppression. Cell. 75:1993;817-825
34. 1 cyclin-dependent kinases. Cell. 75:1993;805-816
35. WAF1/cip1 gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a western-style high-risk diet by altering cell maturation in the intestinal mucosa. Cancer Res. 61:2001;565-569
36. kip1 is sufficient for large and small intestinal tumorigenesis in the mouse, which can be augmented by a western-style high-risk diet. Cancer Res. 63:2003;4990-4995
37. Hu Y.J., Diamond A.M. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res. 63:2003;3347-3351
38. Ratnasinghe D., Tangrea J.A., Andersen M.R., Barrett M.J., Virtamo J., Taylor P.R., Albanes D. Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Res. 60:2000;6381-6383
39. Fong L.Y.Y., Ishii H., Nguyen V.T., Vecchione A., Farber J.L., Croce C.M., Huebner K. P53 deficiency accelerates induction and progression of esophageal and forestomach tumors in zinc-deficient mice. Cancer Res. 63:2003;186-195
40. Soussi T. The p53 tumor suppressor gene: from molecular biology to clinical investigation. Ann. N.Y. Acad. Sci. 910:2000;137-139
41. Srivastava S., Zou Z.Q., Pirolla K., Blattner W., Chang E.H. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature. 348:1990;747-749
42. Calle E.E., Rodriquez C., Walker-Thurmond K., Thun M.J. Overweight obesity, and mortality from cancer in a prospectively studies cohort of US adults. N. Engl. J. Med. 348:2003;1625-1638
43. James S.J., Muskhelishvili L., Gaylor D.W., Turturro A., Hart R. Upregulation of apoptosis with dietary restriction: implications for carcinogenesis and aging. Environ. Health Perspect. 106:1998;307-312
44. Hursting S.D., Perkins S.N., Brown C.C., Haines D.C., Phang J.M. Calorie restriction induces a p53-independent delay of spontaneous carcinogenesis in p53-deficient and wild-type mice. Cancer Res. 57:1997;2843-2846
45. Dunn S.E., Kari F.W., French J., Leininger L.R., Travlos G., Wilson R., Barrett J.C. Dietary restriction reduces insulin-growth factor I levels, which modulates apoptosis, cell proliferation and tumor progression in p53-deficient mice. Cancer Res. 21:1997;4667-4672
46. Berrigan D., Perkins S.N., Haines D.C., Hursting S.D. Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice. Carcinogenesis. 5:2002;817-822
47. Min mice through different mechanisms. Cancer Res. 63:2003;1752-1755
48. Huang X.E., Hamajima N., Saito T., Matsuo K., Mizutani M., Iwata H., Iwase T., Miura S., Mizuno T., Tokudome S., Tajima K. Possible association of beta2- and beta3-adrenergic receptor gene polymorphisms to breast cancer. Breast Cancer Res. 3:2001;264-269
49. Takezaki T., Hamajima N., Matsuo K., Tanaka R., Hirai T., Kato T., Ohashi K., Tajima K. Association of polymorphisms in the beta-2 and beta-3 adrenorecptor genes with risk of colorectal cancer in Japanese. Int. J. Clin. Oncol. 6:2001;117-122
50. Spiegelman B.M., Flier J.S. Adipogenesis and obesity: rounding out the big picture. Cell. 87:1996;377-389
51. Smith W.M., Zhou X.P., Kurose K., Gao X., Latiff F., Kroll T., Sugano K., Cannistra S.A., Clinton S.K., Maher E.R., Prior T.W., Eng C. Opposite association of two PPARG variants with cancer: overrepresentation of H449H in endometrial carcinoma cases and under representation of P12A in renal cell carcinoma cases. Hum. Genet. 109:2001;146-151
52. Loktionov A. Common gene polymorphisms in nutrition: emerging links with pathogenesis of multifactorial chronic diseases. J. Nutr. Biochem. 14:2003;426-451
53. Mao J.-H., Balmain A. Genomic approaches to identification of tumour-susceptiblity genes using mouse models. Curr Opin Genet. Develop. 13:2003;14-19
54. Watson P.W., Commins S.P., Beiler R.J., Hatcher H.C., Gettys T.W. Differential regulation of leptin expression and function in A/J vs. C57BL/6J mice during diet-induced obesity. Am. J. Physiol. Endocrinol. Metab. 279:2000;E356-E365
55. Shepel L.A., Gould M.N. The genetic components of susceptibility to breast cancer in the rat. Prog. Exp. Tumor Res. 35:1999;158-169
56. Shull J.D., Pennington K.L., Reindl T.M., Snyder M.C., Strecker T.E., Spady T.J., Tochacek M., McComb R.D. Susceptibility to estrogen-induced mammary cancer segregates as an incompletely dominant phenotype in reciprocal crosses between the ACI and Copenhagen rat strains. Endocrinology. 142:2001;5124-5130
57. Muller M., Kersten S. Nutrigenomics: goals and strategies. Nat Rev. 4:2003;315-322
58. Slonim D.K. From patterns to pathways: gene expression data analysis comes of age. Nat. Genet. 32:2002;509-514
59. Quackenbush J. Microarray data normalization and transformation. Nat. Genet. 32:2002;496-501
60. Churchill G.A. Fundamentals of experimental design for cDNA microarrays. Nat. Genet. 32:2002;490-495
61. Stoeckert C.J., Causton H.C., Ball C.A. Microarray databases: standards and ontologies. Nat. Genet. 32:2002;469-473
62. Lee C.K., Klopp R.G., Weindruch R., Prolla T.A. Gene expression profile of aging and its retardation by caloric restriction. Science. 285:1999;1390-1393
63. Lee C.K., Weindruch R., Prolla T.A. Gene-expression profile of the ageing brain in mice. Nat. Genet. 25:2000;294-297
64. Weindruch R., Kayo T., Lee C.K., Prolla T.A. Gene expression profiling of aging using DNA microarrays. Mech. Ageing Dev. 123:2002;177-193
65. Jiang W., Zhu Z., Thompson H.J. Effect of energy restriction on cell cycle machinery in 1-methyl-1-nitrosurea-induced mammary carcinomas in rats. Cancer Res. 63:2003;1228-1234
66. Rao L., Puschner B., Prolla T.A. Gene expression profiling of low selenium status in the mouse intestine: transcriptional activation of genes linked to DNA damage. J. Nutr. 131:2001;3175-3181
67. Dong Y., Ganther H.E., Stewart C., Ip C. Identification of molecular targets associated with selenium-induced growth inhibition in human breast cells using cDNA microarrays. Cancer Res. 62:2002;708-714
68. Dong Y., Zhang H., Hawthorn L., Ganther H.E., Ip C. Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array. Cancer Res. 63:2003;52-59
69. van Ommen B., Stierum R. Nutrigenomics: exploiting systems biology in the nutrition and health arena. Curr Opin Biotechnol. 13:2002;517-521
70. Mariadason J.M., Corner G.A., Augenlicht L.H. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac and curcumin and implication for chemoprevention of colon cancer. Cancer Res. 60:2000;4561-4572
71. Hayes J.D., McMahon M. Molecular basis for the contribution of the ARE to cancer chemoprevention. Cancer Lett. 174:2001;103-113
72. Ren B., Thelan A.P., Peters J.M., Gonzalez F.J., Jump D.B. Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor-α J. Biol. Chem. 272:1997;26827-26832
73. Dallongeville J., Bauge E., Tailleux A., Peters J.M., Gonzalez F.J., Fruchart J.C., Staels B. Peroxisome proliferator-activated receptor alpha is not rate-limiting for the lipoprotein-lowering action of fish oil. J. Biol. Chem. 276:2001;4634-4639
74. Thimmulappa R.K., Mai K.M., Srisuma S., Kensler T.W., Yamamoto M., Biswai S. Identification of Nrf-2 regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 62:2002;5196-5203
75. Kvasnicka F. Proteomics: general strategies and application to nutritionally relevant proteins. J. Chromatogr. B. 787:2003;77-89
76. Marshall T., Williams K.M. Proteomics and its impact upon biomedical science. Br. J. Biomed. Sci. 59:2002;47-64
77. Gygi S.P., Rochon Y., Franza B.R., Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 19:1999;1720-1730
78. Panisko E.A., Conrads T.P., Goshe M.B., Veenstra T.D. The postgenomic age: characterization of proteomes. Exp. Hematol. 30:2002;97-107
79. Knowles L.M., Milner J.A. Dillayl disulphide induces ERK phosphorylation and alters gene expression profiles in human colon tumor cells. J. Nutr. 133:2003;2901-2906
80. Dinkova-Kostova A.T., Holtzdaw W.D., Cole R.N., Itoh K., Wakabayashi N., Katoh Y., Yamamota M., Talalay P. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. PNAS. 99:2002;11908-11913
81. Roberts D.C.K. Biomarkers, yesterday, today and tomorrow: the basis for health claims. Asia Pacific J. Clin. Nutr. 11:2002;S87-S89
82. Witzmann F.A., Grant R.A. Pharmacoproteomics in drug development. Pharmocogenomics J. 3:2003;69-76
83. He Q.-Y., Yip T.-T., Li M., Chiu J.-f. Proteomic analyses of arsenic-induced cell transformation with SELDI-TOF ProteinChip technology. J. Cell Biochem. 88:2003;1-8
84. Tan S., Seow t.K., Linag R.C.M.Y., Koh S., Lee C.P.C., Chung M.C.M., Hooi S.C. Proteome analysis of butyrate-treated human colon cancer cells (HT-29). Int. J. Cancer. 98:2002;523-531
85. Fountoulakis M., Suter L. Proteomic analysis of the rat liver. J. Chromatogr. B. 782:2002;197-218
86. Edvardsson U., von Lowenhielm H.B., Panfilov O., Nystrom A.-C., Nilsson F., Dahllof B. Hepatic protein expression of lean mice and obese diabetic mice treated with peroxisome proliferator-activated receptors activators. Proteomics. 3:2003;468-478
87. Petricoin E.F., Ardekani A., Hitt B.A., Levine P.J., Fusar V.A., Steinberg S.M., Mills G.B., Simone C., Fishman D.A., Kohn E.C., Liotta L.A. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 359:2002;572-577
88. Li J., Zhang Z., Rosenzweig J., Wang Y.Y., Chan D.W. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin. Chem. 48:2002;1296-1304
89. A. Adams, Metabolomics: small molecule 'omics', The Scientist (2003) 38-40.
90. Gates S.C., Sweeley C.C. Qualitative metabolic profiling based on gas chromatography. Clin. Chem. 24:1978;1663-1673
91. German J.B., Roberts M.A., Fay L., Watkins S.M. Metabolomics and individual metabolic assessment: the next great challenge for nutrition. J. Nutr. 132:2002;2486-2487
92. Watkins S.M., German J.B. Toward the implementation of metabolomic assessments of human health and nutrition. Curr. Opin. Biotechnol. 13:2002;512-516
93. Fiehn O. Combining genomics, metabolome analysis, and biochemical modeling to understand metabolic networks. Comp. Funct. Genom. 2:2001;155-168
94. Watkins S.M., Hammock B.D., Newman J.W., German J.B. Individual metabolism should guide agriculture toward foods for improved health and nutrition. Am. J. Clin. Nutr. 74:2001;283-286
95. Watkins S.M., Lin T.Y., Davis R.M., Ching J.R., DePeters E.J., Halpern G.M., Walzem R.L., German J.B. Unique phospholipid metabolism in mouse heart in response to dietary docosahexaenoic or α-linolenic acids. Lipids. 36:2001;247-254
96. Watkins S.M., Reifsnyder P.R., Pan H., German J.B., Leiter E.H. Lipid metabolome-wide effects fo the PPARγ agonist rosiglitazone. J. Lipid Res. 43:2002;1809-1811
97. Fitzgerald D.A. Drug discovery: lipid profiling for studying the metabolome. Gen. Eng. News. 21:2001;32-36
98. Noguchi Y., Sakai R., Kimura T. Metabolomics and its potential for assessment of adequacy and safety of amino acid intake. J. Nutr. 133:2003;2097S-2100S
99. Solansky K.S., Bailey N.J.C., Holmes E., Lindon J.C., Davis A.L., Mulder T.P.J., Van Duynhoven J.P.M., Nicholson J.K. NMR-based metabonomic studies on the biochemical effects of epicatechin in the rat. J. Agric. Food Chem. 51:2003;4139-4145
100. 1H nuclear magnetic resonance-based metabonomic techniques for the analysis of the biochemical effects of dietary isoflavones on human plasma profile Anal. Biochem. 323:2003;197-204
101. Shi H., Vigneau-Callahan K.E., Shestopalov A.I., Milbury P.E., Matson W.R., Kristal B.S. Characterization of diet-dependent metabolic serotypes: proof of principle in female and male rats. J. Nutr. 132:2002;1031-1038
102. Shi H., Vigneau-Callahan K.E., Shestopalov A.I., Milbury P.E., Matson W.R., Kristal B.S. Characterization of diet-dependent metabolic serotypes: primary validation of male and female serotypes in independent cohorts of rats. J. Nutr. 132:2002;1039-1046
103. Mazurek S., Eigenbrodt E. The tumor metabolome. Anticancer Res. 23:2003;1149-1154
104. Semenza G.L. Hypoxia inducible factor-1: oxygen homeostasis and disease pathophysiology. Trends Mol. Med. 7:2001;345-350
105. Griffiths J.R., Stubbs M. Opportunities for studying cancer by metabolomics: preliminary observations on tumors deficient in hypoxia-inducible factor 1. Adv. Enzyme Regul. 43:2003;67-76